Oncologists' agreement on adjuvant therapy recommendations and the need of 21-gene recurrence score assay in HR+/HER2-early breast cancer

被引：0
|
作者：
Castro-Henriques, M. [1 ]
Casadevall Aguilar, D. [2 ]
Monzonis, X. [2 ]
Martinez-Garcia, M. [2 ]
Martos, T. [2 ]
Corbera, A. [2 ]
Trias Bes, I. Tusquets [2 ]
Albanell, J. [2 ]
Servitja, S. [2 ]
机构：
[1] HM Hosp, Hosp HM Delfos, Ctr Integral Oncol Clara Campal HM CIOCC, Dept Med Oncol, Barcelona, Spain
[2] Hosp del Mar, Med Oncol Dept, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.308
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
186P
引用
收藏
页码：S317 / S317
页数：1
相关论文
共 50 条
  • [21] First prospective multicenter Italian study on the impact of the 21-Gene Recurrence Score (RS) in adjuvant clinical decisions for ER+/HER2-early breast cancer (BC) patients.
    Dieci, Maria Vittoria
    Guarneri, Valentina
    Giarratano, Tommaso
    Mion, Marta
    Tortora, Giampaolo
    Morandi, Paolo
    Gori, Stefania
    Merlini, Laura
    Oliani, Cristina
    Pasini, Felice
    Bonciarelli, Giorgio
    Griguolo, Gaia
    Orvieto, Enrico
    Del Bianco, Paola
    De Salvo, Gian Luca
    Conte, Pier Franco
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [22] Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer
    Rutter, Charles E.
    Yao, Xiaopan
    Mancini, Brandon R.
    Aminawung, Jenerius A.
    Chagpar, Anees B.
    Saglam, Ozlen
    Hofstatter, Erin W.
    Abu-Khalaf, Maysa
    Gross, Cary P.
    Evans, Suzanne B.
    CLINICAL BREAST CANCER, 2016, 16 (01) : 59 - 62
  • [23] Use of 21-gene recurrence score assay to individualize adjuvant chemotherapy recommendations in ER+/HER2- node positive breast cancer-A National Cancer Database study
    Peethambaram, Prema P.
    Hoskin, Tanya L.
    Day, Courtney N.
    Goetz, Matthew P.
    Habermann, Elizabeth B.
    Boughey, Judy C.
    NPJ BREAST CANCER, 2017, 3
  • [24] First prospective multicenter Italian study on the impact of the 21-gene recurrence score (RS) in adjuvant clinical decisions for ER1/HER2-early breast cancer (BC) patients
    Dieci, M. V.
    Guarneri, V.
    Giarratano, T.
    Mion, M.
    Tortora, G.
    Morandi, P.
    Gori, S.
    Merlini, L.
    Oliani, C.
    Pasini, F.
    Bonciarelli, G.
    Griguolo, G.
    Orvieto, E.
    Del Bianco, P.
    De Salvo, G. L.
    Conte, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [25] Omission of Chemotherapy in HR+/HER2-Early Invasive Breast Cancer Based on Combined 6-IHC Score?
    Lin, Jiaman
    Guo, Zihe
    Wang, Shuo
    Zheng, Xinyu
    CLINICAL BREAST CANCER, 2021, 21 (05) : E565 - E574
  • [26] PALLAS: A randomized phase III trial of adjuvant palbociclib with endocrine therapy versus endocrine therapy alone for HR+/HER2-early breast cancer
    Mayer, E. L.
    Gnant, M. I.
    DeMichele, A.
    Martin, M.
    Burstein, H.
    Prat, A.
    Rubovszky, G.
    Miller, K. D.
    Pfeiler, G.
    Winer, E. P.
    Zdenkowski, N.
    Anderson, D.
    Nowecki, Z.
    Loibl, S.
    Fohler, H.
    Metzger, O.
    Fumagalli, D.
    Theall, K. Puyana
    Fesl, C.
    Dueck, A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1145 - S1145
  • [27] A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer
    Gong, Gyungyub
    Kwon, Mi Jeong
    Han, Jinil
    Lee, Hee Jin
    Lee, Se Kyung
    Lee, Jeong Eon
    Lee, Seon-Heui
    Park, Sarah
    Choi, Jong-Sun
    Cho, Soo Youn
    Ahn, Sei Hyun
    Lee, Jong Won
    Cho, Sang Rae
    Moon, Youngho
    Nam, Byung-Ho
    Nam, Seok Jin
    Choi, Yoon-La
    Shin, Young Kee
    SCIENTIFIC REPORTS, 2017, 7
  • [28] Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients
    Zeng, Yufei
    Gao, Weiqi
    Chen, Xiaosong
    Shen, Kunwei
    CANCER BIOMARKERS, 2022, 35 (01) : 111 - 118
  • [29] Metabolic syndrome and breast cancer recurrence within the 21-gene recurrence score assay.
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, Norah Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [30] Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, N. Lynn
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 597 - 603
12345